
Universal Health International Group Holding Limited
2211.HKHKSEHealthcareMedical - Pharmaceuticals
Latest quote
HK$0.785
+HK$0.025 · +3.29%
2211.HK company overview
Regular session · HKT · Market data may be delayed.
Company profile
Company websiteOperating as an investment holding company, Universal Health International Group Holding Limited specializes in the wholesale, retail, and distribution of a comprehensive range of pharmaceutical and healthcare products across China's northeastern region. Its extensive offerings span both Western and traditional Chinese medicines, including patent medicines, chemical preparations, antibiotics, biochemical and biological drugs, traditional Chinese medicine decoction pieces, protein assimilation preparations, peptide hormones, and blood products. The company also supplies medical equipment, disinfection products, nutritional and prepackaged foods, health care items, cosmetics, daily necessities, and specific consumer goods such as family planning supplies (e.g., contraceptives) and infant formula milk powder. Furthermore, Universal Health International Group Holding Limited provides storage services to its varied clientele, which includes pharmaceutical retailers, hospitals, clinics, and distributors. Founded in 1998, the enterprise was formerly known as Jintian Pharmaceutical Group Limited until its rebranding in July 2015, and its corporate headquarters are located in Shenyang, People's Republic of China.
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- Headquarters
- CN
- CEO
- Chuanfu Chu
- Listed since
- Dec 12, 2013
- Employees
- 665
Market position
- Volume
- 7.38M
- 3.69× average
- Average volume
- 2M
- Average daily volume
- Market cap
- 69.7M HKD
- Beta
- -0.52
- Market reference 1
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 97.1M CNY
- P/E (TTM)
- -2.38×
- P/B (TTM)
- 0.19×
- P/S (TTM)
- 0.11×
- EV / EBITDA
- -8.2×
- Earnings yield
- -30.41%
- Free cash flow yield
- -70.07%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 16.84%
- Operating margin
- -3.91%
- Net margin
- -4.48%
- Return on equity
- -8.19%
- Return on assets
- -5.81%
- Return on invested capital
- -7.46%
Financial health
- Debt / equity
- 0.19×
- Current ratio
- 1.31×
Earnings
- Latest EPS result
- -0.01
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Corporate actions
Corporate action history
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
Dividend | Sep 17, 2015 | HK$0.0002Quarterly | Sep 18, 2015 | Oct 5, 2015 |
Dividend | Jun 18, 2015 | HK$0.0003Semi-Annual | Jun 19, 2015 | Jul 7, 2015 |
Dividend | Sep 18, 2014 | HK$0.0003Semi-Annual | Sep 19, 2014 | Oct 6, 2014 |
Ex-dividend Sep 17, 2015
HK$0.0002
Quarterly
Record Sep 18, 2015 · Payment Oct 5, 2015
Ex-dividend Jun 18, 2015
HK$0.0003
Semi-Annual
Record Jun 19, 2015 · Payment Jul 7, 2015
Ex-dividend Sep 18, 2014
HK$0.0003
Semi-Annual
Record Sep 19, 2014 · Payment Oct 6, 2014
2211.HK peers
Continue in GoAI
Research 2211.HKresearch.disclaimer





